TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

Primary Blood Grouping

Test and evaluation
UK
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS Blood and Transplant: "Primary Blood Grouping". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityNHS Blood and TransplantScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: NHS Blood and Transplant
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for NHS Blood and Transplant. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
3Bids / Report
36.7% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 103 active published awards; 90 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityNHS Blood and Transplant
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSFramework
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published17 Jan 2023, 11:22 GMT
Last source update17 Jan 2023, 11:22 GMT
Recurring procurementNot published
ClassificationTest and evaluation
Delivery area
UK
OCIDocds-h6vhtk-032d95
What is being bought
Provision of a Primary Blood Grouping Managed Service to the Authority (NHS Blood and Transplant). The Service will be provided over two sites namely, Manchester and Filton.
What changed
From the official release history
  1. tender value changed
    17 Jan 2023, 11:22 GMT
  2. Status changed to complete
    17 Jan 2023, 11:22 GMT
  3. Official notice release published
    17 Jan 2023, 11:22 GMT
  4. Submission deadline changed to published date
    17 Jan 2023, 11:22 GMT
  5. Buyer information updated
    17 Jan 2023, 11:22 GMT
  6. Published value updated to £50,000,000
    13 Apr 2022, 21:13 BST
  7. Status changed to active
    13 Apr 2022, 21:13 BST
  8. Official notice release published
    13 Apr 2022, 21:13 BST
  9. Submission deadline changed to 28 Apr 2022, 01:00 BST
    13 Apr 2022, 21:13 BST
  10. Buyer information updated
    13 Apr 2022, 21:13 BST
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    cancelled
    Published valueNot published
    NHSBT requires a direct contractual relationship with either the manufacturer or any other economic operator for a complete end-to-end integrated Service, which must include all the necessary Equipment, Goods, Installation, maintenance, Consumables, Reagents, Software, including an inter-operability provision with NHSBT’s existing IT infrastructure, and an overall on-going support mechanism that may be required to carry out the necessary testing as stated below.<br/>All invitro diagnostic medical devices, for example, Instruments, Consumables and Reagents must be CE/UKCA marked. GB will continue to recognise CE marking under the IVDD or IVDR until 30 June 2023 and from 1 July 2023 devices placed on the GB market must be UKCA marked under the UK MDR 2002 as amended.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    17 Jan 2023, 11:22 GMT
  2. Award active
    Not published · Not published
  3. Contract active
    Signed 16 Jan 2023, 00:00 GMT · £18,200,000
Commercial outcome and competition
Awards
BECKMAN COULTER UNITED KINGDOM LIMITED
Not published · Not published · active
Contracts
Contract
£18,200,000 · signed 16 Jan 2023, 00:00 GMT · active
Bid statistics
bids: 2 (lot 1)
Buyer and organisations in this procedure

NHS Blood and Transplant

Contracting authority GB-FTS-18293
View buyer profile

  • NHS Blood and Transplant
    buyer

    500 North Bristol Park, Bristol, UKK11, BS34 7QH
    jo.murphy@nhsbt.nhs.uk
    +44 1179212718

  • BECKMAN COULTER UNITED KINGDOM LIMITED
    supplier

    Oakley Court, Kingsmead Business Park, London Road, High Wycombe, UK, HP11 1JU

  • The High Court
    mediationBody
    reviewBody
    reviewContactPoint

    The Strand, London, WC2A 2LL
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published